AVITA Medical (AVHHL) Short term Debt (2025 - 2026)
AVITA Medical's (AVHHL) quarterly Short term Debt came in at $46.7 million in Q2 2026, up 1455.3% on a YoY basis from $3.0 million in Q2 2025, and up 8.55% quarter-over-quarter from $43.0 million in Q4 2025.
Powered by 
Analysis
AVITA Medical (AVHHL) Short term Debt (2025 - 2026) Analysis & Trends
AVITA Medical (AVHHL) has reported Short term Debt for 2 consecutive years, with $46.7 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Short term Debt rose 1455.3% year-over-year to $46.7 million; the trailing twelve-month figure through Jun 2026 stood at $46.7 million (up 1455.3% YoY), and the FY2025 full-year result was $43.0 million, changed N/A from the prior year.
- Short term Debt rose to $46.7 million in Q2 2026 per AVHHL's latest filing, from $43.0 million in the prior quarter.
- Across five years, Short term Debt topped out at $46.7 million in Q2 2026 and bottomed at $3.0 million in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.89 Bn | 179.29 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.33 Bn | 119.12 Bn | 1.96 Bn |
| 3 | Medtronic | 118.33 Bn | 109.51 Bn | 6.34 Bn |
| 4 | Stryker | 104.48 Bn | 101.01 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.98 Bn | 66.44 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.79 Bn | 45.54 Bn | 1.35 Bn |
| 7 | Alcon | 33.96 Bn | 32.50 Bn | 1.68 Bn |
| 8 | Dexcom | 32.28 Bn | 30.33 Bn | 830.00 Mn |
| 9 | Steris | 21.14 Bn | 20.66 Bn | 684.20 Mn |
| 10 | AVITA Medical | 61.85 Mn | 50.72 Mn | 17.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 46.66 Mn |
| Dec 31, 2025 | 42.98 Mn |
| Sep 30, 2025 | 42.45 Mn |
| Jun 30, 2025 | 3.00 Mn |
| Mar 31, 2025 | 3.00 Mn |